Nanotherapeutics-mediated tolerogenic induction for enabling adeno-associated virus vector gene therapy re-administration by overcoming anti-drug antibodies
Materials Horizons · 2025
DOI: 10.1039/d5mh00203f ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Horizons, 2025. Verfasst von Yubo Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, P. R. China. liuhongzhuo@syphu.edu.cn. Hauptthemen laut MEDLINE: Dependovirus, Genetic Therapy, Genetic Vectors, Immune Tolerance. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Shenyang Municipal Bureau of Science and Technology, Department of Education of Liaoning Province.
Abstract (Originalsprache)
Utilizing co-assembled nanoparticles composed of lipidated rapamycin and itaconic acid to enable repeatable administration of recombinant adeno-associated virus vectors by eliminating the formation of anti-drug antibodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, P. R. China. liuhongzhuo@syphu.edu.cn.
- Shenyang Sunshine Pharmaceuticals Co., Ltd., Shenyang, 110016, P. R. China.
- Department of Respiratory Medicine, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121001, P. R. China.
Förderung
- Shenyang Municipal Bureau of Science and Technology
- Department of Education of Liaoning Province
Zitieren
APA
Liu, Y., Liang, F., Zhang, R., Tang, C., Li, X., Wang, Y., He, Z., & Liu, H. (2025). Nanotherapeutics-mediated tolerogenic induction for enabling adeno-associated virus vector gene therapy re-administration by overcoming anti-drug antibodies. Materials Horizons. https://doi.org/10.1039/d5mh00203f
Vancouver
Liu Y, Liang F, Zhang R, Tang C, Li X, Wang Y, et al. Nanotherapeutics-mediated tolerogenic induction for enabling adeno-associated virus vector gene therapy re-administration by overcoming anti-drug antibodies. Materials Horizons. 2025. doi:10.1039/d5mh00203f
BibTeX
@article{Liu2025,
author = {Liu, Yubo and Liang, Fangming and Zhang, Rui and Tang, Chengcheng and Li, Xin and Wang, Yongjun and He, Zhonggui and Liu, Hongzhuo},
title = {Nanotherapeutics-mediated tolerogenic induction for enabling adeno-associated virus vector gene therapy re-administration by overcoming anti-drug antibodies},
journal = {Materials Horizons},
year = {2025},
doi = {10.1039/d5mh00203f}
}
EUVIMED